Whalegun
Home

Regeneron Pharmaceuticals REGN filed Q4 2023 lobbying · under $5,000

Trade details

Type
Lobbying report
Amount
Under $5,000
Quarter
Q4 2023
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
24/01/16

$2.1M on lobbying in 2023

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN filed Q4 2023 lobbying · under $5,000 | Whalegun